Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 3Not yet recruiting 2Completed 2Active not recruiting 2Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 660Carcinoma, Non-Small-Cell Lung 454Prostatic Neoplasms 384Neoplasms 376Lung Neoplasms 261Multiple Myeloma 246Colorectal Neoplasms 231Neoplasm Metastasis 214Melanoma 202Leukemia, Myeloid, Acute 165Ovarian Neoplasms 163Pancreatic Neoplasms 155Carcinoma, Renal Cell 141Squamous Cell Carcinoma of Head and Neck 137Lymphoma 134Brain Neoplasms 132Leukemia, Lymphocytic, Chronic, B-Cell 126Glioblastoma 126Recurrence 123Lymphoma, Non-Hodgkin 123Carcinoma, Hepatocellular 117Head and Neck Neoplasms 114Urinary Bladder Neoplasms 111Triple Negative Breast Neoplasms 107Stomach Neoplasms 106Precursor Cell Lymphoblastic Leukemia-Lymphoma 104Uterine Cervical Neoplasms 100Hematologic Neoplasms 99Lymphoma, Follicular 95Sarcoma 93

Interventions

Spermine Synthase 1Palliative Care 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Cognition Disorders × 1 year × Clear all
NCT03606421 2026-03-06

CBF and NCF Changes With Brain Radiation

University Health Network, Toronto

Active not recruiting
110 enrolled
CNS

Brain Neoplasms, Cognition Disorders

NCT04586530 2026-01-21

TAMS

University of Pittsburgh

Phase NA Active not recruiting
220 enrolled

Chemotherapy-Related Cognitive Impairment, Cognition Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡